Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$299,134,267
+$165,147,694 QoQ
Shares Held
249,397
+71.2% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
2.35%
of 13F equity value
Holder Rank
#215
of 4,605 holders
Holding Since
Dec 2022
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Derivatives in LLY
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$269,871,772
PutShares
225,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Marex Group plc holds $405,541,812 across 9 Drug Manufacturers - General names. LLY ranks #1 (73.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
249,397 | $299,134,267 | |
| 2 | AMGN |
Amgen Inc
|
197,671 | $71,580,622 | |
| 3 | NVO |
Novo Nordisk A S
|
518,286 | $24,846,630 | |
| 4 | PFE |
Pfizer Inc
|
178,990 | $4,310,079 | |
| 5 | MRK |
Merck & Co., Inc.
|
13,315 | $1,710,977 | |
| 6 | JNJ |
Johnson & Johnson
|
5,784 | $1,468,962 | |
| 7 | ABBV |
AbbVie Inc.
|
5,599 | $1,408,932 | |
| 8 | AZN |
Astrazeneca PLC
|
4,027 | $763,599 |
All Filings in LLY
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $299,134,267 | 249,397 | Shares | Defined | 2026-08-14 | |
| 2026-06-30 | $269,871,772 | 225,000 | Put | Defined | 2026-08-14 | |
| 2026-03-31 | $183,954,000 | 200,000 | Put | Defined | 2026-05-13 | |
| 2026-03-31 | $68,982,750 | 75,000 | Call | Defined | 2026-05-13 | |
| 2026-03-31 | $133,986,573 | 145,674 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $21,493,602 | 20,000 | Put | Defined | 2026-02-12 | |
| 2025-12-31 | $37,260,232 | 34,671 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $284,914,882 | 373,414 | Shares | Defined | 2025-11-14 | |
| 2025-09-30 | $263,235,000 | 345,000 | Put | Defined | 2025-11-14 | |
| 2025-06-30 | $220,217,225 | 282,500 | Put | Defined | 2025-08-19 | |
| 2025-06-30 | $221,703,788 | 284,407 | Shares | Defined | 2025-08-19 | |
| 2025-03-31 | $166,091,326 | 201,101 | Shares | Defined | 2026-04-02 | |
| 2024-12-31 | $172,723,420 | 223,735 | Shares | Defined | 2026-04-02 | |
| 2024-09-30 | $131,320,228 | 148,227 | Shares | Defined | 2026-04-07 | |
| 2024-06-30 | $143,481,905 | 158,477 | Shares | Defined | 2026-04-02 | |
| 2024-03-31 | $120,149,697 | 154,442 | Shares | Defined | 2026-04-02 | |
| 2023-12-31 | $28,032,622 | 48,090 | Shares | Defined | 2026-04-02 | |
| 2023-09-30 | $407,681 | 759 | Shares | Defined | 2026-04-02 | |
| 2023-06-30 | $223,234 | 476 | Shares | Defined | 2026-04-02 | |
| 2022-12-31 | $219,504 | 600 | Shares | Defined | 2026-04-02 | |
| No filing history on record for this holder in this stock. | ||||||